Search Results 1101-1110 of 17881 for monoclonal antibody

1. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Other severe acute or chronic medical (including bone marrow suppressive diseases) ...

2. A Study Of LY2951742 For Patients With Episodic Cluster Headaches - Mayo Clinic

   Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins; A history or presence of other medical illness that indicates ...

3. A Study of the Use of Pembrolizumab (MK-3475) in Patients with Relapsed or Hard to Treat Classical Hodgkin Lymphoma - Mayo Clinic

   Prior monoclonal antibody within 4 weeks prior to study Day 1; Prior Chemotherapy, targeted small molecular therapy, or radiation therapy within 2 weeks ...

4. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody within 4 weeks of Study Day 1 or who has not recovered from adverse events due to agents administered >4 weeks ...

5. Dose Escalation Study With Bispecific Antibodies In Adult Patients With Lupus Nephritis - Mayo Clinic

   This study is researching a particular group of experimental drugs administered for a short period in the treatment of patients with Lupus Nephritis (LN). The ...

6. A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets - Mayo Clinic

   therapy, including a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL ...

7. Study shows drug reduces risk of relapse with neuromyelitis optica - Mayo Clinic News Network

   ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with ...

8. Safety Study Of Viaskin® Peanut Patch In Peanut-Allergic Children 1 Through 3 Years Of Age (COMFORT Toddlers) - Mayo Clinic

   * Treatment with any monoclonal antibody or biologic immunomodulatory therapy within 6 months prior to Visit 1. * Uncontrolled persistent asthma ...

9. Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

   composition to nivolumab (Parts A+ B) and/or ipilimumab (Part B) - History of severe hypersensitivity reaction to any monoclonal antibody - Uncontrolled ...

10. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

    ... monoclonal antibody or kinase inhibitor. Participation in clinical trials ... Use of any neutralizing monoclonal antibodies such as bamlanivimab (LY ...